Xtrackers DAX UCITS ET (DBXD.ETF)

Close: 209.15 (+1.50), Apr 25, 2025
Weak Negative

Low risk

Automatic technical analysis. Short term, Apr 25, 2025

Xtrackers DAX UCITS ETF 1C is within an approximate horizontal trend channel in the short term. This indicates that investors are uncertain and waiting for signals of further direction. A break upwards will be a positive signal, while a break downwards will be a negative signal. The price has reacted back after a break of the rectangle formation. There is resistance around 210, which now opens good sales opportunities. A decisive break of this resistance will neutralize the negative signal. The ETF is testing resistance at euro 210. This could give a negative reaction, but an upward breakthrough of euro 210 means a positive signal. Negative volume balance indicates that volume is high on days with falling prices and low on days with rising prices, which weakens the ETF. The ETF is overall assessed as technically slightly negative for the short term.

Recommendation one to six weeks: Weak Negative (Score: -34)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.70%8.86+0.72%
5 days39.982.28%9.99+4.42%
22 days-44.405.88%17.18-2.81%
66 days-38.7211.50%13.67+5.91%

More analyses of Xtrackers DAX UCITS ETF 1C

chart Xtrackers DAX UCITS ETF 1C (DBXD) Candlesticks 22 Days
Candlesticks
chart Xtrackers DAX UCITS ETF 1C (DBXD) Short term
Short term: Weak Negative
chart Xtrackers DAX UCITS ETF 1C (DBXD) Medium term
Medium term: Weak Positive
chart Xtrackers DAX UCITS ETF 1C (DBXD) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.